z-360
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2005 (NCT00288925)
Timeline
Indications
Mechanism of action
- Cholecystokinin receptorINHIBITOR
Cholecystokinin receptor inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- z-360
- z-360
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02117258 | Phase 2 | Apr 1, 2014 | Zeria Pharmaceutical |
| NCT01776463 | Phase 1 | Jan 1, 2013 | Sumida, Zeria Pharmaceutical |
| NCT00288925 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2005 | University of London, Zeria Pharmaceutical |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zeria Pharmaceutical | For profit | 3 | 3 | 2 | 2005 |
| Sumida | For profit | 1 | 0 | 1 | 2013 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2005 |
3 organizations
Page 1 / 1